COVID-19 Outbreak and BNT162b2 mRNA Vaccination Coverage in a Correctional Facility during Circulation of the SARS-CoV-2 Omicron BA.1 Variant in Italy
<b>Background</b>. The recent spread of the highly mutated SARS-CoV-2 Omicron variant (B.1.1.529) has raised concerns about protection against COVID-19 in congregate settings such as prisons, characterized by a high risk of transmission and possible difficulties in obtaining adequate vac...
Main Authors: | Angela Stufano, Nicola Buonvino, Claudia Maria Trombetta, Daniela Pontrelli, Serena Marchi, Giuseppe Lobefaro, Leonarda De Benedictis, Eleonora Lorusso, Maria Teresa Carofiglio, Violetta Iris Vasinioti, Emanuele Montomoli, Nicola Decaro, Piero Lovreglio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/7/1137 |
Similar Items
-
Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection
by: Chaitanya Kurhade, et al.
Published: (2022-12-01) -
Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: the early Omicron era
by: Shanti Pather, et al.
Published: (2023-12-01) -
Evaluation of antibody response to SARS-CoV-2 variants after 2 doses of mRNA COVID-19 vaccine in a correctional facility
by: Claudia Maria Trombetta, et al.
Published: (2022-12-01) -
Correlation of Binding and Neutralizing Antibodies against SARS-CoV-2 Omicron Variant in Infection-Naïve and Convalescent BNT162b2 Recipients
by: Jia Fu, et al.
Published: (2022-11-01) -
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022
by: Lamprini Veneti, et al.
Published: (2023-05-01)